RMMI Corp. Announces Filing of an Amended and Restated Final Prospectus with Respect to its Initial Public Offering

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF U.S. SECURITIES LAWS.

Calgary, Alberta, June 26, 2018 – RMMI Corp. (“RMMI”) announced today that it has obtained a receipt for its amended and restated final long form prospectus (the “Amended Prospectus”) filed with the securities regulatory authorities in the Provinces of Alberta, British Columbia and Ontario in connection with the proposed initial public offering of RMMI’s common shares at a price of $2.50 per common share. The final long form prospectus filed on June 22, 2018 did not include a complete set of RMMI’s financial statements due to a clerical error. RMMI has filed an Amended Prospectus with financial statements included in the Amended Prospectus. Other than the inclusion of the applicable financial statements of RMMI, no material changes or revisions have been made in the Amended Prospectus.

No securities regulatory authority has either approved or disapproved of the contents of this news release. The common shares have not been and will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”) or any state securities laws. Accordingly, the common shares may not be offered or sold within the United States unless registered under the U.S. Securities Act and applicable state securities laws or pursuant to exemptions from the registration requirements of the U.S. Securities Act and applicable state securities laws. This news release does not constitute an offer to sell or a solicitation of an offer to buy any securities of RMMI in any jurisdiction in which such offer, solicitation or sale would be unlawful.

About RMMI Corp.

RMMI is an Alberta based company that will focus on the production, cultivation and sale of medical marijuana in various forms, including dried marijuana and cannabis oil. RMMI, through its wholly-owned subsidiary, Rocky Mountain Marijuana Inc., has applied for a Licence to Produce under the Access to Cannabis for Medical Purposes Regulations (Canada). RMMI is currently at a development stage and has yet to obtain the requisite licence to commence operations.

For more information about RMMI, please visit https://www.rmmi.ca.

For more information, please contact:

RMMI Corp.
#1050 – 639-5th Avenue S.W.
Calgary, AB T2P 0M9

Earl Connors, President and Chief Executive Officer
403-984-6446
ec@rmmi.ca

Peter Cheung